. (GMTX)
- - (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
. (GMTX)
-
- (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
White William Richard | Director | May 01, 2024 | Option Exercise | $9.86 | 201 | 1,982 | 201 | May 03, 2024, 04:05 PM |
White William Richard | Director | May 01, 2024 | Sale | $28.63 | 201 | 5,755 | 39 | May 03, 2024, 04:05 PM |
White William Richard | Director | Apr 11, 2024 | Option Exercise | $4.91 | 2,560 | 12,581 | 2,560 | Apr 15, 2024, 06:27 PM |
White William Richard | Director | Apr 11, 2024 | Sale | $31.80 | 2,560 | 81,407 | 78 | Apr 15, 2024, 06:27 PM |
Savage William Jacob | Chief Medical Officer | Apr 10, 2024 | Option Exercise | $2.65 | 21,870 | 57,956 | 43,405 | Apr 11, 2024, 05:02 PM |
Bitterman Kevin | Director | Mar 05, 2024 | Sale | $73.50 | 26,157 | 1,922,540 | 677,503 | Mar 07, 2024, 04:40 PM |
Bitterman Kevin | Director | Jan 23, 2024 | Sale | $67.65 | 102,500 | 6,934,125 | 703,660 | Jan 25, 2024, 04:33 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Jan 23, 2024 | Sale | $67.65 | 102,500 | 6,934,125 | 703,660 | Jan 25, 2024, 04:31 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Jan 23, 2024 | Sale | $67.65 | 47,500 | 3,213,375 | 1,402,186 | Jan 25, 2024, 04:31 PM |
Bitterman Kevin | Director | Jan 10, 2024 | Sale | $64.00 | 20,000 | 1,280,000 | 786,160 | Jan 12, 2024, 05:12 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Jan 10, 2024 | Sale | $64.00 | 20,000 | 1,280,000 | 786,160 | Jan 12, 2024, 05:12 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Jan 10, 2024 | Sale | $64.00 | 30,000 | 1,920,000 | 1,449,686 | Jan 12, 2024, 05:12 PM |
Bryce Joanne | Chief Financial Officer | Dec 27, 2023 | Option Exercise | $9.86 | 3,000 | 29,580 | 5,500 | Dec 29, 2023, 04:15 PM |
ORBIMED ADVISORS LLC | Director | Dec 18, 2023 | Option Exercise | $38.00 | 1,724 | 65,512 | 1,724 | Dec 20, 2023, 06:28 PM |
ORBIMED ADVISORS LLC | Director | Dec 18, 2023 | Sale | $59.24 | 1,724 | 102,130 | 0 | Dec 20, 2023, 06:28 PM |
Ashiya Mona | Director | Dec 18, 2023 | Option Exercise | $38.00 | 1,724 | 65,512 | 1,724 | Dec 20, 2023, 06:16 PM |
Ashiya Mona | Director | Dec 18, 2023 | Sale | $59.24 | 1,724 | 102,130 | 0 | Dec 20, 2023, 06:16 PM |
Ashiya Mona | Director | Dec 14, 2023 | Sale | $56.75 | 433,200 | 24,584,100 | 897,625 | Dec 15, 2023, 06:09 PM |
ORBIMED ADVISORS LLC | Director | Dec 14, 2023 | Sale | $56.75 | 433,200 | 24,584,100 | 897,625 | Dec 15, 2023, 06:04 PM |
Bitterman Kevin | Director | Dec 13, 2023 | Sale | $60.00 | 3,548 | 212,865 | 826,749 | Dec 14, 2023, 08:14 PM |
Bitterman Kevin | Director | Dec 12, 2023 | Sale | $62.80 | 51,967 | 3,263,328 | 861,401 | Dec 14, 2023, 08:14 PM |
Bitterman Kevin | Director | Dec 14, 2023 | Sale | $58.28 | 20,549 | 1,197,567 | 806,280 | Dec 14, 2023, 08:14 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Dec 12, 2023 | Sale | $62.80 | 51,967 | 3,263,328 | 861,401 | Dec 14, 2023, 08:13 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Dec 12, 2023 | Sale | $62.80 | 77,951 | 4,895,032 | 1,562,550 | Dec 14, 2023, 08:13 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Dec 14, 2023 | Sale | $58.28 | 20,549 | 1,197,567 | 806,280 | Dec 14, 2023, 08:13 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Dec 14, 2023 | Sale | $58.28 | 30,825 | 1,796,437 | 1,479,866 | Dec 14, 2023, 08:13 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Dec 13, 2023 | Sale | $60.00 | 3,548 | 212,865 | 826,749 | Dec 14, 2023, 08:13 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Dec 13, 2023 | Sale | $60.00 | 5,323 | 319,357 | 1,510,571 | Dec 14, 2023, 08:13 PM |
ORBIMED ADVISORS LLC | Director | Dec 14, 2023 | Sale | $57.73 | 200 | 11,546 | 1,126,125 | Dec 14, 2023, 05:44 PM |
ORBIMED ADVISORS LLC | Director | Dec 13, 2023 | Sale | $58.56 | 106,700 | 6,248,352 | 1,126,225 | Dec 14, 2023, 05:44 PM |
ORBIMED ADVISORS LLC | Director | Dec 12, 2023 | Sale | $60.16 | 27,300 | 1,642,368 | 1,182,425 | Dec 14, 2023, 05:44 PM |
Ashiya Mona | Director | Dec 12, 2023 | Sale | $60.16 | 27,300 | 1,642,368 | 1,182,425 | Dec 14, 2023, 05:40 PM |
Ashiya Mona | Director | Dec 14, 2023 | Sale | $57.73 | 200 | 11,546 | 1,126,125 | Dec 14, 2023, 05:40 PM |
Ashiya Mona | Director | Dec 13, 2023 | Sale | $58.56 | 106,700 | 6,248,352 | 1,126,225 | Dec 14, 2023, 05:40 PM |
White William Richard | Director | Dec 12, 2023 | Option Exercise | $6.08 | 33,511 | 203,883 | 33,511 | Dec 14, 2023, 04:15 PM |
White William Richard | Director | Dec 12, 2023 | Sale | $63.21 | 33,511 | 2,118,239 | 21,411 | Dec 14, 2023, 04:15 PM |
Bryce Joanne | Chief Financial Officer | Dec 12, 2023 | Option Exercise | $2.65 | 2,500 | 6,625 | 5,000 | Dec 14, 2023, 04:15 PM |
Bryce Joanne | Chief Financial Officer | Dec 12, 2023 | Sale | $65.22 | 2,500 | 163,062 | 2,500 | Dec 14, 2023, 04:15 PM |
Bryce Joanne | Chief Financial Officer | Dec 05, 2023 | Option Exercise | $1.01 | 1,281 | 1,294 | 5,041 | Dec 07, 2023, 04:15 PM |
Bryce Joanne | Chief Financial Officer | Dec 05, 2023 | Sale | $56.00 | 2,541 | 142,299 | 3,893 | Dec 07, 2023, 04:15 PM |
Khara Rahul | General Counsel | Nov 22, 2023 | Option Exercise | $14.69 | 10,000 | 146,900 | 10,000 | Nov 27, 2023, 04:15 PM |
Khara Rahul | General Counsel | Nov 22, 2023 | Sale | $51.73 | 10,000 | 517,333 | 9,900 | Nov 27, 2023, 04:15 PM |
Khara Rahul | General Counsel | Nov 14, 2023 | Option Exercise | $14.69 | 4,900 | 71,981 | 4,900 | Nov 15, 2023, 05:00 PM |
Khara Rahul | General Counsel | Nov 14, 2023 | Sale | $50.61 | 4,900 | 248,012 | 787 | Nov 15, 2023, 05:00 PM |
Khara Rahul | General Counsel | Nov 03, 2023 | Option Exercise | $14.69 | 100 | 1,469 | 100 | Nov 07, 2023, 06:22 PM |
Khara Rahul | General Counsel | Nov 03, 2023 | Sale | $50.00 | 100 | 5,000 | 0 | Nov 07, 2023, 06:22 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Sep 16, 2023 | Sale | $53.22 | 2,115 | 112,560 | 1,593,785 | Sep 18, 2023, 04:59 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Sep 15, 2023 | Sale | $53.16 | 260,894 | 13,869,125 | 1,595,900 | Sep 18, 2023, 04:59 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Sep 14, 2023 | Sale | $53.05 | 94,440 | 5,010,042 | 1,856,794 | Sep 18, 2023, 04:59 PM |
Bryce Joanne | Chief Financial Officer | Sep 11, 2023 | Option Exercise | $9.86 | 2,500 | 24,650 | 3,760 | Sep 13, 2023, 04:15 PM |
Bryce Joanne | Chief Financial Officer | Sep 01, 2023 | Option Exercise | $2.65 | 1,000 | 2,650 | 2,260 | Sep 05, 2023, 04:16 PM |
Bryce Joanne | Chief Financial Officer | Sep 01, 2023 | Sale | $52.99 | 1,000 | 52,990 | 1,260 | Sep 05, 2023, 04:16 PM |
Savage William Jacob | Chief Medical Officer | Aug 21, 2023 | Option Exercise | $2.65 | 3,000 | 7,950 | 3,000 | Aug 22, 2023, 04:06 PM |
Bitterman Kevin | Director | Aug 15, 2023 | Sale | $52.40 | 72,931 | 3,821,585 | 882,224 | Aug 17, 2023, 04:13 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Aug 15, 2023 | Sale | $52.40 | 72,931 | 3,821,585 | 882,224 | Aug 16, 2023, 06:55 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Aug 15, 2023 | Sale | $52.40 | 111,069 | 5,820,016 | 1,951,234 | Aug 16, 2023, 06:55 PM |
Atlas Venture Fund X, L.P. | 10% Owner | Aug 14, 2023 | Sale | $52.59 | 175,000 | 9,203,600 | 2,162,303 | Aug 16, 2023, 06:55 PM |
Savage William Jacob | Chief Medical Officer | Aug 15, 2023 | Sale | $52.95 | 7,672 | 406,235 | 3,964 | Aug 16, 2023, 04:15 PM |
Savage William Jacob | Chief Medical Officer | Aug 09, 2023 | Sale | $49.83 | 8,269 | 412,064 | 12,741 | Aug 11, 2023, 04:15 PM |
Bryce Joanne | Chief Financial Officer | Aug 01, 2023 | Option Exercise | $1.01 | 4,521 | 4,566 | 5,781 | Aug 03, 2023, 04:18 PM |
Bryce Joanne | Chief Financial Officer | Aug 01, 2023 | Sale | $49.91 | 4,521 | 225,633 | 2,714 | Aug 03, 2023, 04:18 PM |
MacDonald Brian Richard | Chief Innovation Officer | Jun 30, 2023 | Sale | $45.26 | 4,924 | 222,836 | 14,277 | Jun 30, 2023, 06:29 PM |
MacDonald Brian Richard | Chief Innovation Officer | Jun 29, 2023 | Sale | $45.79 | 5,100 | 233,509 | 21,564 | Jun 30, 2023, 06:29 PM |
MacDonald Brian Richard | Chief Innovation Officer | Jun 28, 2023 | Sale | $49.96 | 5,100 | 254,795 | 25,153 | Jun 30, 2023, 06:29 PM |
Bryce Joanne | Chief Financial Officer | Jun 28, 2023 | Option Exercise | $1.01 | 7,880 | 7,959 | 11,332 | Jun 30, 2023, 04:49 PM |
Bryce Joanne | Chief Financial Officer | Jun 28, 2023 | Sale | $49.95 | 10,072 | 503,114 | 6,524 | Jun 30, 2023, 04:49 PM |
Savage William Jacob | Chief Medical Officer | Jun 28, 2023 | Sale | $49.98 | 4,384 | 219,114 | 18,805 | Jun 30, 2023, 04:12 PM |
Novo Holdings A/S | 10% Owner | Jun 28, 2023 | Sale | $46.10 | 1,250,000 | 57,624,998 | 1,090,772 | Jun 28, 2023, 05:04 PM |
Ashiya Mona | Director | Feb 15, 2023 | Buy | $23.00 | 108,696 | 2,500,008 | 1,196,825 | Feb 17, 2023, 04:48 PM |
ORBIMED ADVISORS LLC | Director | Feb 15, 2023 | Buy | $23.00 | 108,696 | 2,500,008 | 1,196,825 | Feb 17, 2023, 04:43 PM |
AI DMI LLC | 10% Owner | Feb 15, 2023 | Buy | $23.00 | 434,783 | 10,000,009 | 3,141,759 | Feb 17, 2023, 04:42 PM |
Leonard Braden Michael | 10% Owner | Oct 26, 2022 | Sale | $2.09 | 22,500 | 47,025 | 247,500 | Oct 27, 2022, 04:23 PM |
Piekos Brian | CFO | May 31, 2022 | Option Exercise | $1.09 | 9,960 | 10,856 | 17,615 | Jun 02, 2022, 07:14 PM |
Leonard Braden Michael | 10% Owner | Apr 13, 2022 | Buy | $1.52 | 191,769 | 291,604 | 5,000,000 | Apr 13, 2022, 04:09 PM |
Leonard Braden Michael | 10% Owner | Apr 12, 2022 | Buy | $1.42 | 203,744 | 290,193 | 4,808,231 | Apr 13, 2022, 04:09 PM |
Leonard Braden Michael | 10% Owner | Apr 11, 2022 | Buy | $1.35 | 504,487 | 681,057 | 4,604,487 | Apr 13, 2022, 04:09 PM |
Leonard Braden Michael | 10% Owner | Apr 12, 2022 | Buy | $1.37 | 55,000 | 75,075 | 270,000 | Apr 13, 2022, 04:09 PM |
Tananbaum James B. | Director | Feb 05, 2021 | Option Exercise | $10.00 | 1,500,000 | 15,000,000 | 1,500,000 | Feb 09, 2021, 04:00 PM |
FS Development Holdings, LLC | 10% Owner | Feb 05, 2021 | Option Exercise | $10.00 | 1,500,000 | 15,000,000 | 1,500,000 | Feb 09, 2021, 03:04 PM |
FS Development Holdings, LLC | 10% Owner | Aug 14, 2020 | Buy | $10.00 | 441,500 | 4,415,000 | 441,500 | Oct 19, 2020, 08:49 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR
STOCK BUYBACKS FOR
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.54%
1Q
06/30/2023
13.79%
2Q
03/31/2023
28.98%
3Q
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...